Catalyst Wire Dossier Catalyst Wire Dossier

AE-941 (Neovastat)

AE-941
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AE-941 (Neovastat), covering 2013-01-23 to 2013-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]

See pricing